InternationalFachagentur Nachwachsende Rohstoffe e. V.

 

News

ERA CoBioTech launched a Call for Experts

The ERA-NET Cofund on Biotechnologies (ERA CoBioTech) is looking forward to select two high-level experts with expertise in social and policy science and biotechnology to develop a joint Policy Brief.

The current call is addressed toexperts in biotechnology and social sciences, who are interested tofacilitate the process of development of a joint document based on the outcomes of ERA CoBioTech and its funded projects condensing the new knowledge generated, policy and technology-related challenges and lessons learned towards further research.

The joint Policy Brief is expected to comprise key findings, recommendations, demands and open challenges identified from the projects funded under ERA-CoBioTech’s umbrella. In order to involve all relevant stakeholders in the preparation of the document, a joint workshop (involving experts and project representatives), will be arranged to discuss the document’s scope, structure and reach.

The final document will include recommendations and key data to explore the disruptive potential of the remarkable key-enabling technologies involved in all ERA-CoBioTech’s projects (such as synthetic biology, systems biology, -omics…) and identify most relevant challenges ahead.

This call for experts is framed within ERA-CoBioTech’s Additional Activities programme, which apart from joint calls for research proposals, also includes a variety of actions intended to support, train and help its stakeholders to obtain the maximum impact from their research efforts.

ERA-CoBiotech is more than a mere R&D funding programme but it takes a proactive approach to project and programme management in order to contribute turning frontier science and technological visions into real market opportunities.

Application shall be submitted via the ERA-CoBioTech Submission Form by the deadline 6th December, 2021 at 13:00 CET.

All details are available in the Call Announcement.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 722361.

FNR contact person: Dr. Boris Vashev

 

ERA CoBioTech

ERA CoBioTech